NCT01674985 Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes Status COMPLETED Phase PHASE1/PHASE2
NCT01571648 A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic Syndromes Status COMPLETED Phase PHASE1
NCT01546337 Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome Status TERMINATED Phase N/A
NCT01519011 Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine Status COMPLETED Phase PHASE1
NCT01496495 A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes Status COMPLETED Phase PHASE1
NCT01488253 Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants Status TERMINATED Phase PHASE2
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Status COMPLETED Phase PHASE1
NCT01417767 Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS Status UNKNOWN Phase PHASE2/PHASE3
NCT01409070 Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome Status COMPLETED Phase N/A
NCT01400633 An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome Status COMPLETED Phase N/A
NCT01390311 Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT01386619 NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Status COMPLETED Phase PHASE1/PHASE2
NCT01381809 An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes Status COMPLETED Phase PHASE3
NCT01350245 Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor Status COMPLETED Phase PHASE2
NCT01324960 Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes Status WITHDRAWN Phase PHASE1/PHASE2
NCT01302106 Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes Status WITHDRAWN Phase PHASE2
NCT01246076 Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents Status COMPLETED Phase PHASE2